In a prospective cohort from the Third China National Stroke Registry study (n = 10,700), elevated MCP-1 levels were associated with a 35% increased risk of all-cause mortality and a 19% higher likelihood of poor functional outcomes after ischemic stroke or transient ischemic attack. Here, CCL2 is linked to ischemic stroke.